Evolution of the Average Target: Shield Therapeutics plc

Evolution of the Target Price: Shield Therapeutics plc

Changes in Analyst Recommendations: Shield Therapeutics plc

61e482.5VyNMhxyf7-1zR33uqLFRHiPuzKC9ToNM405UV1V-9E.oh_ZAVEBGYzMq0rAw_KacEDe7XHajX9Zeu9WADM8vZWRLsxxU0opzue_TA~0500b9d3f77c61e1f94e31c612467e3d

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+6.12%
-34.35%
+0.04%
+44.41%
+34.69%
+4.68%
+2.49%
+24.87%
+13.95%
Average +10.77%
Weighted average by Cap. +6.58%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.0485GBP
Average target price
0.1667GBP
Spread / Average Target
+243.65%
High Price Target
0.2300GBP
Spread / Highest target
+374.23%
Low Price Target
0.1200GBP
Spread / Lowest Target
+147.42%

Analyst Consensus Detail

Consensus revision (last 18 months)

Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
  1. Stock Market
  2. Stocks
  3. STX Stock
  4. SHIE.F Stock
  5. Consensus Shield Therapeutics plc